High-grade Sarcomatous Overgrowth in Solitary Fibrous Tumors
- 1 August 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 36 (8), 1202-1215
- https://doi.org/10.1097/pas.0b013e31825748f0
Abstract
We describe 10 solitary fibrous tumors (SFT) with high-grade malignant overgrowth, all of which showed the presence of a synchronous or previous classic SFT/malignant SFT (MSFT) component. Seven were "dedifferentiated," with an abrupt transition from a classic SFT/MSFT to a high-grade component consisting of a nondistinctive high-grade sarcoma in 4 cases and divergent differentiation in 3. The nondistinctive high-grade component consisted of epithelioid and/or spindle cells often associated with overt pleomorphism or small round cell sarcomas. The divergent differentiation featured a rhabdomyosarcoma in 2 cases and an osteosarcoma in 1. Three cases (tentatively called "evolved") showed a gradual transition from classic SFT/MSFT to a nondistinctive high-grade sarcoma or presented features of high-grade sarcoma at the time of metastasis (assessed by fine-needle aspiration cytology) without any component suggesting a diagnosis of classic SFT/MSFT. The high-grade component showed loss of CD34 expression in half of the dedifferentiated SFTs and all of the dedifferentiated SFTs with divergent differentiation, whereas Ki-67 was markedly increased in all of the evaluable cases and paralleled the tumor grade. In 4 cases, the expression and phosphorylation status of key factors that control transcription and protein synthesis were also investigated. Both S6 and 4E-BP1 showed low activation in the low-grade MSFT and a high level of activation in the high-grade component. Seven of the 10 patients died of their disease during follow-up, with a median overall survival of 73 months (range, 5 to 288 mo). The median time to distant metastasis was 156 months after the initial diagnosis, and median overall survival from the first signs of metastasis was 8 months.Keywords
This publication has 28 references indexed in Scilit:
- From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of RapamycinJournal of Clinical Oncology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in CancerClinical Cancer Research, 2010
- Sunitinib Malate and Figitumumab in Solitary Fibrous Tumor: Patterns and Molecular Bases of Tumor ResponseMolecular Cancer Therapeutics, 2010
- A comprehensive map of the mTOR signaling networkMolecular Systems Biology, 2010
- Solitary fibrous tumour of the kidney with sarcomatous overgrowth . Case report and review of the literatureAPMIS, 2008
- The eIF4E RNA regulon promotes the Akt signaling pathwayThe Journal of cell biology, 2008
- Malignant transformation of a solitary fibrous tumor of the liver and intractable hypoglycemiaJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Chromosomal imbalances in a recurrent solitary fibrous tumor of the orbitCancer Genetics and Cytogenetics, 2005
- Pelvic hemangiopericytomas: A report of five cases and literature reviewGynecologic Oncology, 1990